dr. dreicer on the current role of abiraterone and enzalutamide in prostate cancer
Published 7 years ago • 199 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:09
dr. dreicer on resistance to antiandrogen therapy in prostate cancer
-
1:02
dr. robert dreicer discusses sequencing mdv3100 and abiraterone
-
1:14
dr. robert dreicer discusses using abiraterone acetate
-
0:52
dr. robert dreicer on potential combinations in prostate cancer
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
0:50
dr. dreicer on future treatment approaches in prostate cancerdreicer
-
0:59
dr. crawford on abiraterone versus enzalutamide in prostate cancer
-
0:51
dr. dreicer on the optimal use of radium-223 in prostate cancer
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
1:01
dr. robert dreicer on utilizing new prostate cancer therapies
-
0:53
dr. dreicer on combinations and sequencing agents with immunotherapies in prostate cancer
-
8:12
the use of abiraterone and enzalutamide against crpc
-
0:53
dr. robert dreicer on drug development challenges in prostate cancer
-
1:18
dr. robert dreicer on sequencing therapies in prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:08
dr. graff on the use of abiraterone in metastatic prostate cancer
-
0:49
dr. dreicer on trial endpoints in prostate cancer